Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 4/20 | 0.80 |
| ▸ | PCNA | P12004 | 2/20 | 0.68 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | USP2 | O75604 | 1/20 | 0.58 |
| ▸ | EGFR | P00533 | 1/20 | 0.58 |
| ▸ | LCK | P06239 | 1/20 | 0.58 |
| ▸ | FYN | P06241 | 1/20 | 0.58 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.58 |
| ▸ | HTR2A | P28223 | 1/20 | 0.58 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.58 |
| ▸ | RECQL | P46063 | 1/20 | 0.58 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.58 |
| ▸ | ALPI | P09923 | 1/20 | 0.58 |
| ▸ | PKM | P14618 | 1/20 | 0.58 |
| ▸ | XIAP | P98170 | 1/20 | 0.58 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL285216 | 1.00 | SLC7A5 (0.80) | SLC7A5PCNAPTGS1KDM4EUSP2 | |
| SCHEMBL29556905 | 1.00 | SLC7A5 (0.80) | SLC7A5PCNAPTGS1KDM4EUSP2 | |
| SCHEMBL30622075 | 1.00 | SLC7A5 (0.80) | SLC7A5PCNAPTGS1KDM4EUSP2 | |
| Iodide SCHEMBL4670395 | 0.98 | SLC7A5 (0.77) | SLC7A5PCNAPTGS1KDM4EUSP2 | |
| SCHEMBL29455798 | 0.98 | SLC7A5 (0.77) | SLC7A5PCNAPTGS1KDM4EUSP2 | |
| SCHEMBL28173375 | 0.98 | SLC7A5 (0.77) | SLC7A5PCNAPTGS1KDM4EUSP2 | |
| Iodide SCHEMBL4672201 | 0.98 | SLC7A5 (0.77) | SLC7A5PCNAPTGS1KDM4EUSP2 | |
| 2-Mercaptoethanol SCHEMBL27826214 | 0.91 | SLC7A5 (0.67) | SLC7A5PCNAPTGS1KDM4EUSP2 | |
| Tyrosine SCHEMBL1580 | 0.89 | SLC7A5 (1.00) | SLC7A5PCNAPTGS1KDM4EUSP2 | |
| Tyrosine SCHEMBL11676367 | 0.89 | SLC7A5 (1.00) | SLC7A5PCNAPTGS1KDM4EUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 960 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4749284-A1 | DETERMINATION OF FREE THYROID HORMONE | pes Diagnosesysteme GmbH (DE) | 2026-05-27 | — | — | EP | claimed |
| EP-3869192-B1 | METHOD FOR QUANTITATIVE DETECTION OF VARIOUS METABOLITES IN BIOLOGICAL SAMPLE | HUMAN METABOLOMICS INST INC (CN) | 2026-05-13 | — | — | EP | claimed |
| US-12600953-B2 | Compositions and method for establishing organoid cultures from cryogenically preserved tissue | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2026-04-14 | — | — | US | claimed |
| US-12580229-B2 | Unit cell including thermochromic polymer and defect detection method using the same | LG ENERGY SOLUTION, LTD. (KR) | 2026-03-17 | — | — | US | claimed |
| EP-4688727-A1 | NOVEL L-THYROXINE RADIOIODINE LABEL AND PROCESS FOR PRODUCTION THEREOF | Forschungszentrum Jülich GmbH (DE) | 2026-02-11 | — | — | EP | claimed |
| US-12534706-B2 | Method for maturation of retinal tissue containing continuous epithelium | RIKEN (JP) | 2026-01-27 | — | — | US | claimed |
| US-12428447-B2 | Peptide-based non-proteinaceous cargo delivery | FELDAN BIO INC. (CA) | 2025-09-30 | — | — | US | claimed |
| EP-4605516-A1 | GENERATION OF SECRETOME-CONTAINING COMPOSITIONS, AND METHODS OF USING AND ANALYZING THE SAME | FUJIFILM Cellular Dynamics, Inc. (US) | 2025-08-27 | — | — | EP | claimed |
| US-20250258146-A1 | QUANTITATIVE DETECTION METHOD OF MULTIPLE METABOLITES IN BIOLOGICAL SAMPLE AND METABOLIC CHIP | HUMAN METABOLOMICS INSTITUTE INC. (CN) | 2025-08-14 | — | — | US | claimed |
| US-12378529-B2 | Method for culturing colorectal cancer solid tumor primary cells and colorectal cancer ascites primary tumor cells and supporting reagents | GENEX HEALTH CO., LTD (CN) | 2025-08-05 | — | — | US | claimed |
| WO-2002089917-A2 | DERMATOLOGICAL FORMULATIONS | KARO BIO AB (SE) | 2002-11-14 | — | — | WO | claimed |
| US-20020123521-A1 | Treatment for dermal skin atrophy using thyroid hormone compounds or thyroid hormone-like compounds | KOO, CATHERINE, DR | 2002-09-05 | — | — | US | claimed |
| US-6380255-B1 | TOPICALLY APPLYING TO SKIN THYROID HORMONE COMPOUND TOGETHER WITH A BASE FOR THERAPY OF SKIN ATROPHY | KARO BIO AB (SE) | 2002-04-30 | — | — | US | claimed |
| WO-2002005834-A2 | NOVEL USES FOR THYROID HORMONES OR THYROID HORMONE-LIKE AGONIST COMPOUNDS FOR TREATING DERMIS CONDITIONS | KARO BIO AB (SE) | 2002-01-24 | — | — | WO | claimed |
| US-6221911-B1 | REDUCING SUBCUTANEOUS FAT DEPOSITS IN A SUBJECT; IMPROVING THE SKIN CONDITION OF A SUBJECT | KARO BIO AB (SE) | 2001-04-24 | — | — | US | claimed |
| EP-0831769-A2 | NOVEL USES FOR THYROID HORMONES OR THYROID HORMONE-LIKE COMPOUNDS | KARO BIO AB (SE) | 1998-04-01 | — | — | EP | claimed |
| US-5658885-A | OLIGOPEPTIDES; ANTICOAGULANTS; ENZYME INHIBITORS; THROMBIN | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-08-19 | — | — | US | claimed |
| WO-1996040048-A9 | NOVEL USES FOR THYROID HORMONES OR THYROID HORMONE-LIKE COMPOUNDS | — | 1997-03-27 | — | — | WO | claimed |
| WO-1996040048-A2 | NOVEL USES FOR THYROID HORMONES OR THYROID HORMONE-LIKE COMPOUNDS | KARO BIO AB (SE) | 1996-12-19 | — | — | WO | claimed |
| US-4299812-A | Immunoassay of thyroxine in neonates using dried blood samples | DIAGNOSTIC PRODUCTS CORP. (US) | 1981-11-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12600953-B2 | Compositions and method for establishing organoid cultures from cryogenically preserved tissue | BMP4, DSP, WNT3A | SLC7A5 4806/4885PCNA 1784/4885PTGS1 1862/4885 |
| US-12580229-B2 | Unit cell including thermochromic polymer and defect detection method using the same | MKI67, BPNT1, TRDMT1 | SLC7A5 1774/4885PCNA 70/4885PTGS1 3791/4885 |
| US-12534706-B2 | Method for maturation of retinal tissue containing continuous epithelium | ALDH1A2, DCX, BDNF | SLC7A5 842/4885PCNA 805/4885PTGS1 420/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.